
ENHERTU: A NEW LIFESAVER?
Enhertu (chemical name: fam-trastuzumab-deruxtecan-nxki) is approved by the U.S. Food and Drug Administration to treat currently incurable HER-2-positive breast cancer and metastatic HER2-positive breast cancer that has been treated with two or more anti-HER2 therapies/medicines. About one out of every four breast cancers is HER2-positive. Doctors call Enhertu an antibody-drug










